Features | Partner Sites | Information | LinkXpress
Sign In

Retinal Imaging Detects Changes Associated with Alzheimer's Disease

By Medimaging International staff writers
Posted on 23 Jul 2014
Image: Amyloid plaques showing up in retinal scan as fluorescent spots as curcumin binds to them (Photo courtesy of CSIRO).
Image: Amyloid plaques showing up in retinal scan as fluorescent spots as curcumin binds to them (Photo courtesy of CSIRO).
A noninvasive optical imaging device can provide early detection of changes that later occur in the brain and are a classic sign of Alzheimer's disease (AD), according to a new study.

Researchers at the Commonwealth Scientific and Industrial Research Organization (CSIRO, Melbourne, Australia) conducted a study to measure retinal beta-amyloid plaque in 40 volunteers, using a fluorescence-based scan that was compared to the results of brain positron emission tomography (PET) scans using the Pittsburgh Compound B (PiB) amyloid tracer. The researchers used orally administered curcumin as a tracer, on the basis of previous research indicating that it binds beta-amyloid protein with high affinity.

The researchers found that besides correlating strongly with plaque burden estimates from PiB-based PET scans, the retinal scans distinguished patients with AD from other participants with 100% sensitivity and a specificity of 80.6%. For the study, the researchers used the NeuroVision system, a product of NeuroVision Imaging (Sacramento, CA, USA), which provides a count of beta-amyloid plaques in the retina, their two-dimensional (2D) extent in square microns, and their distribution. All three parameters are combined into a "retinal amyloid index" to provide a single-number estimate of beta-amyloid plaque burden.

The Australian study is one of several in progress to determine if similar results can be confirmed in humans living with the disease. The study involves a total of 220 patients composed of diagnosed with AD, including a group with mild cognitive impairment, another group of people with no evidence of brain abnormality, and controls. The study was presented at the Alzheimer's Association International Conference, held during July 2014 in Copenhagen (Denmark).

“All people with the disease tested positive and most of the people without the disease tested negative,” said lead author and study presenter Shaun Frost, MSc, BSc, a biomedical scientist at CSIRO. “The optical imaging exam appears to detect changes that occur 15–20 years before clinical diagnosis. It's a practical exam that could allow testing of new therapies at an earlier stage, increasing our chances of altering the course of Alzheimer's disease.”

“PET scans require the use of radioactive tracers, and cerebrospinal fluid analysis requires that patients undergo invasive and often painful lumbar punctures,” said Prof. Keith Black, MD, chair of the department of neurosurgery at Cedars-Sinai Hospital (Los Angeles, CA, USA), who helped develop the NeuroVision system. “The retina, unlike other structures of the eye, is part of the central nervous system, sharing many characteristics of the brain. By staining the plaque with curcumin […] we could detect it in the retina even before it began to accumulate in the brain.”

Curcumin, a major component of the yellow Indian spice turmeric, has fluorescent properties, and is also believed to have a variety of medicinal qualities.

Related Links:
Commonwealth Scientific and Industrial Research Organization
NeuroVision Imaging



view channel
Image: Multimodal CT images obtained 2 hours 18 minutes after symptom onset in an 87-year-old woman with an NIH Stroke Scale of 15 and left hemisphere symptoms (Photo courtesy of Radiology 2015:257;2;510-520, and RSNA 2015).

Faster and Simpler Treatment for Stroke Patients Using Multiphase CT

The results of a new study show that multiphase Computed Tomography (CT) angiography brain-imaging could enable clinicians to treat Acute Ischemic Stroke (AIS) patients faster, and better, potentially saving lives.... Read more

Nuclear medicine

view channel
Image: The whole body of a rat can be imaged for blood clots with one PET scan, overlaid here on an MRI image, using the FBP8 probe. The arrow points to a blood clot (Photo courtesy of the American Chemical Society).

Single PET Scan Could Replace Multiple Modalities in Detecting Blood Clots

Researchers have presented an experimental technique that could be used to discover blood clots using a single, fast, whole-body scan, at the 250th National Meeting and Exposition of the American Chemical... Read more

General/Advanced Imaging

view channel

Leading Vendor to Implement and Install Enterprise Imaging Platform for UK NHS

An agreement has been announced by a leading imaging platform provider for the implementation of the first Enterprise Imaging platform, part of a long-term agreement for the management of imaging data, for the UK City Hospitals Sunderland NHS Foundation Trust. The agreement covers the capture, storage, and exchange of... Read more

Imaging IT

view channel

Carestream Updates Healthcare IT Platform

Carestream has released updates for an advanced Internet Technology (IT) healthcare platform at the Röntgenveckan Radiology congress in Malmo (Sweden). The IT platform facilitates collaboration by enabling sharing of critical patient information such as Radiology images, videos, reports, and services with groups outside... Read more

Industry News

view channel

Viztek Acquired by Konica Minolta to Complement End-to-End Healthcare IT Solutions

Konica Minolta Medical Imaging (Wayne, NJ, USA), a leading medical diagnostic primary imaging provider, has announced the completed acquisition of Viztek (Garner, NC, USA), a company providing Healthcare Internet Technology solutions. The acquisition enhances Konica Minolta’s end-to-end healthcare IT capabilities, including... Read more
Copyright © 2000-2015 Globetech Media. All rights reserved.